These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2397007)

  • 1. Synthesis and platelet aggregation inhibitory effects of N-[(1H-pyrazol-1-yl)alkyl]benzoylamides.
    Ferroni R; Milani L; Simoni D; Orlandini P; Bottura M; Bardi A; Guarneri M
    Arzneimittelforschung; 1990 Jun; 40(6):705-9. PubMed ID: 2397007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-(1H-pyrazol-1-yl)-2-butylamine derivatives as inhibitors of blood platelet aggregation.
    Ferroni R; Milani L; Simoni D; Orlandini P; Guarneri M; Franzé D; Bardi A
    Farmaco; 1989 May; 44(5):495-502. PubMed ID: 2506876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
    Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis and platelet aggregation inhibitory activity of analogues of 4-([2-(1H-imidazol-1-yl)-1-(4-substituted-phenyl)ethoxy]methyl)benzoic acids].
    Wu QY; Yang JQ
    Yao Xue Xue Bao; 1991; 26(10):741-6. PubMed ID: 1823715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
    Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
    Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and inhibitory activities on platelet aggregation of some flavonoid analogues.
    Göker H; Tunçbilek M; Leoncini G; Buzzi E; Mazzei M; Rolland Y; Ertan R
    Arzneimittelforschung; 1995 Feb; 45(2):150-5. PubMed ID: 7710437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.
    Hsieh PW; Chiang SZ; Wu CC; Lo YC; Shih YT; Wu YC
    Bioorg Med Chem; 2008 May; 16(10):5803-14. PubMed ID: 18407506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of N1-substituted benzamidines. Effects on blood coagulation, platelet aggregation and antiarrhythmic activity.
    Ferroni R; Simoni D; Manfredini S; Guarneri M; Orlandini P; Barbieri M; Franzè GP; Mugelli A
    Arzneimittelforschung; 1995 Jun; 45(6):665-9. PubMed ID: 7646567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic guanidines: synthesis and antiplatelet activity of 4,6,7,8-tetrahydro-1H-imidazo[1,2-a]pyrazolo[3,4-d]pyrimidin-7-ones and 1,4,6,7,8,9-hexahydropyrazolo [3',4':4,5]pyrimido[2,1-c] [1,2,4]triazin-7-ones.
    Ferroni R; Simoni D; Orlandini P; Bardi A; Franze GP; Guarneri M
    Arzneimittelforschung; 1990 Dec; 40(12):1328-31. PubMed ID: 2095128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
    Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
    Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New chiral inhibitors of induced platelet aggregation: the enantiomeric specificity of (R)- and (S)-methyl and ethyl esters of 1-(4-[(1-hydroxycarbonyl)-ethoxy]-benzyl)-1H-1,2,3-triazole as a tool for determining their biological target.
    Biagi G; Giorgi I; Livi O; Scartoni V; Catalani R; Gervasi G
    Farmaco; 1996 Dec; 51(12):761-6. PubMed ID: 9050207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives.
    Chen HS; Kuo SC; Teng CM; Lee FY; Wang JP; Lee YC; Kuo CW; Huang CC; Wu CC; Huang LJ
    Bioorg Med Chem; 2008 Feb; 16(3):1262-78. PubMed ID: 17988878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
    Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
    Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of platelet aggregation inhibitory activity of some 3-phenyl-pyrroloquinazolinones.
    Ferlin MG; Borgo C; Deana R
    Eur J Med Chem; 2012 Feb; 48():275-83. PubMed ID: 22236469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,5-Diphenyl-1H-pyrazole derivatives. IV--N,N-disubstituted 3-(3,5-diphenyl-1H-pyrazol-1-yl)propanamides and 3-(3,5-diphenyl-1H-pyrazol-1-yl)propanamines with sedative, platelet antiaggregating and local anesthetic activities.
    Bondavalli F; Bruno O; Ranise A; Schenone P; Losasso C; Donnoli D; Stella L; Marmo E
    Farmaco; 1990 Feb; 45(2):137-46. PubMed ID: 2133991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and platelet aggregation inhibitory activity of 6-substituted dihydropyridazinones].
    Yao FM; Sun CS
    Yao Xue Xue Bao; 1993; 28(7):548-52. PubMed ID: 8285059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,5-Diphenyl-1H-pyrazole derivatives. VIII. N-substituted 3-(4-hydroxy-3,5-diphenyl-1H-pyrazol-1-yl)-propanamides, -propanamines and 2-(4-hydroxy-3,5-diphenyl-1H-pyrazol-1-yl)ethanamines with platelet antiaggregating, hypotensive, antiarrhythmic and other activities.
    Bruno O; Bondavalli F; Ranise A; Schenone P; Cenicola ML; Donnoli D; Filippelli W; Losasso C; Costantino M; Marmo E
    Farmaco; 1991 Mar; 46(3):477-99. PubMed ID: 1892504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.